TWi Biotechnology, Inc Statistics
TWi Biotechnology, Inc (6610) Stock Statistics & Valuation Metrics
Total Valuation
TWi Biotechnology, Inc has a market cap or net worth of TWD 4.05B. The enterprise value is ―.
- Market Cap
- TWD 4.05B
- Enterprise Value
- ―
Share Statistics
TWi Biotechnology, Inc has 223,579,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 223,579,390
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TWi Biotechnology, Inc’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -56.12%.
- Return on Equity (ROE)
- -0.32
- Return on Assets (ROA)
- -0.28
- Return on Invested Capital (ROIC)
- -56.12%
- Return on Capital Employed (ROCE)
- -0.56
- Revenue Per Employee
- 0
- Profits Per Employee
- -7.50M
- Employee Count
- 27
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of TWi Biotechnology, Inc is -11.99. TWi Biotechnology, Inc’s PEG ratio is -0.73.
- PE Ratio
- -11.99
- PS Ratio
- 0.00
- PB Ratio
- 7.60
- Price to FCF
- -10.52
- Price to Operating Cash Flow
- -9.79
- PEG Ratio
- -0.73
Income Statement
In the last 12 months, TWi Biotechnology, Inc had revenue of 0 and earned -202.37M in profits. Earnings per share was -1.04.
- Revenue
- 0
- Gross Profit
- -35.32M
- Operating Income
- -357.02M
- Pretax Income
- -357.52M
- Net Income
- -202.37M
- EBITDA
- -321.70M
- Earnings Per Share (EPS)
- -1.04
Cash Flow
In the last 12 months, operating cash flow was -370.61M and capital expenditures -387,000, giving a free cash flow of -370.99M billion.
- Operating Cash Flow
- -370.61M
- Free Cash Flow
- -370.99M
- Free Cash Flow per Share
- -1.79
Dividends & Yields
TWi Biotechnology, Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.35%
- Earnings Yield
- -8.12%
Stock Price Statistics
- Beta
- 0.64
- 52-Week Price Change
- -48.59%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 31.64
- Average Volume (3m)
- 1.62M
Financial Position
TWi Biotechnology, Inc as a current ratio of 2.98, with Debt / Equity ratio of 0.47%
- Current Ratio
- 2.98
- Quick Ratio
- 2.98
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.81
- Interest Coverage Ratio
- -2137.86
Taxes
In the past 12 months, TWi Biotechnology, Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
TWi Biotechnology, Inc EV to EBITDA ratio is -9.36, with an EV/FCF ratio of -10.40.
- EV to Sales
- 0.00
- EV to EBITDA
- -9.36
- EV to Free Cash Flow
- -10.40
- EV to Operating Cash Flow
- -10.41
Balance Sheet
TWi Biotechnology, Inc has TWD 111.85M in cash and marketable securities with TWD 1.60M in debt, giving a net cash position of TWD 110.25M billion.
- Cash & Marketable Securities
- TWD 111.85M
- Total Debt
- TWD 1.60M
- Net Cash
- TWD 110.25M
- Net Cash Per Share
- TWD 0.49
- Tangible Book Value Per Share
- TWD 0.32
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for TWi Biotechnology, Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 14.93%
